Amphastar Grows With Primatene Mist, Epinephrine And Glucagon
As Company Plans Vasopressin Launch in Q3 FY22
Amphastar has reported double-digit growth in the fourth quarter of 2021, as the company sees sales growth from Primatene Mist, epinephrine products and glucagon. The company also revealed that it is anticipating a Q3 FY22 launch of vasopressin.
